Parkwalk News

3 December 2018

Parkwalk wins ‘Best Generalist EIS Fund’ in the Investment Week 2018/19 Tax Efficiency Awards

By |December 3rd, 2018|

Parkwalk are delighted to have won ‘Best General EIS Fund’ at Investment Week’s Tax Efficiency Awards 2018 last week, beating last year’s runner’s up prize and matching our win in 2016.

Parkwalk were also highly commended in the ‘Best Exit’ category.

It is always a good validation of our investment strategy to be recognised by industry peers […]

Deal or no deal, should EIS investors be worried about Brexit?

By |December 3rd, 2018|

Given the UK’s Venture Capital Schemes (SEIS, EIS, VCT and SITR) fall under the EU State Aid rules there is the possibility that a ‘hard’ Brexit would allow the Government to loosen restrictions regarding these schemes, but it seems unlikely given the Government’s agenda.

However, under any compromise deal the UK will probably have to […]

25 November 2018

Oxbotica, AXA XL and Nominet to bring autonomous cars to London roads before Christmas

By |November 25th, 2018|

Today the DRIVEN consortium, led by Oxbotica, the autonomous vehicle software provider, announces it will commence trials on London’s roads this month following successful ongoing trials in Oxford. The vehicles will be mapping the streets of Hounslow and are expected to be autonomous by Christmas 2018. During the trials, Nominet and AXA XL will […]

Tom Hopkins joins Parkwalk

By |November 20th, 2018|

Parkwalk are delighted to announce that Tom Hopkins has joined the team as Business Development Director. Tom has worked alongside Parkwalk since early 2015 as one of the co-founders of Kin Capital who provide fundraising services to the Parkwalk EIS Fund and will continue to do so.

Tom has 13 years’ experience across the front, […]

Parkwalk included in Global University Venturing 2018 Powerlist

By |November 12th, 2018|

Global University Venturing has just completed their inaugural Powerlist for 2018 based on their five-year data review of the university spin-out ecosystem earlier this year.

The data from the study showed Parkwalk as the world’s second most active investor in this sector, which can be seen here: Global investors in University spin-outs 2013 – 2017. Parkwalk […]

Duel – University of Bristol Enterprise Fund II investment

By |November 5th, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Duel.

Duel is a centralised hub for managing Ambassador programs and all elements for Customer Advocacy Marketing for brands. It works by taking customers, turning them into advocates, then empowering these advocates to tell a brand’s story and rigorously track the results. […]

Echion – UCEF V investment

By |November 1st, 2018|

We are delighted to announce that the University of Cambridge Enterprise Fund V has invested in a £1.5 million seed funding round (alongside an additional £600k Innovate UK grant) in to Echion Technologies, a spin-out from the University of Cambridge Engineering Department.

Echion is commercialising superfast charging lithium-ion battery cells for electric vehicles, and is seeking […]

20 October 2018

DefiniGEN – Parkwalk closes follow on investment

By |October 20th, 2018|

Parkwalk closes DefiniGen investment.

DefiniGEN, a spin-out from the University of Cambridge Regenerative Medicine Department at Addenbrooke’s Hospital, have created a stem cell technology to provide human cells to the drug discovery sector for use in lead optimisation and toxicity programmes.

The Company’s proprietary production platform OptiDIFF robustly generates human cell types including using hIPSC human […]

Congenica – earns major role in supporting world’s first routine national genomic medicine service

By |October 17th, 2018|

Genomics England names Congenica as its Clinical Decision Support Service partner for the delivery of the NHS Genomic Medicine Service

Cambridge, United Kingdom – 17 October, 2018 – Congenica has been awarded a multi-year contract by Genomics England, to be a provider of Diagnostic Decision Support Services for them to deliver for the world leading NHS Genomic […]

Oxbotica – appoints Fraser Robinson to drive global strategy

By |October 12th, 2018|

Oxbotica, the autonomous software company, today announces the appointment of Fraser Robinson to its board of directors. This follows Oxbotica’s recent completion of a £14 million investment which will support the next stage of its international development.

Robinson comes with a rare and proven track record, most recently leading Uber’s investment negotiations, strategy and partnerships […]

Vitamica – University of Bristol Enterprise Fund II investment

By |October 9th, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Vitamica, a University of Bristol spin-out that aims to exploit a novel approach for determining the susceptibility of bacteria to antibiotics.

Resistance of bacteria to antibiotics is an increasing problem across the world, resulting in poorer healthcare […]

Paragraf – Large-scale production of graphene-based technologies

By |October 6th, 2018|

Paragraf, the Cambridge graphene start-up, has followed its seed investment of £2.9m, announced in May 2018, with the opening of a groundbreaking new facility

The site represents a turning point for graphene-based technologies, enabling Paragraf to drive large-scale development of mass-market, graphene-based electronic devices.

Paragraf’s proprietary production technique overcomes the quality, contamination and reproducibility barriers faced […]

Arkivum – Jersey Heritage contract

By |October 1st, 2018|

Jersey Heritage has chosen Arkivum Perpetua to store and preserve the huge volumes of digital records in its care. Holding the complete public record of States of Jersey, a photo archive of around 1.5 million images and digitised artefacts such as registration cards from the German occupation during World War Two, Jersey Heritage tells […]

27 September 2018

Healthera – UCEF V investment

By |September 27th, 2018|

We are delighted to announce that the University of Cambridge Enterprise Fund V has invested in a £3m Series A financing round into Healthera, a provider of next-generation, pharmacy-integrated personal health management solutions.

Healthera connects patients to a platform of hundreds of pharmacies and NHS GPs, allowing them to order and track prescriptions, access clinical […]

Oxbotica – Parkwalk investment

By |September 19th, 2018|

Oxbotica, the autonomous vehicle software company, today announces the completion of a £14 million investment to support the next stage of its growth strategy. Funds have been secured from three leading investors: IP Group plc, Parkwalk Advisors and AXA XL (formerly XL Catlin).

The investment will be used to further accelerate Oxbotica’s sustained growth, which […]

AudioTelligence – University of Cambridge Enterprise Fund V investment

By |September 18th, 2018|

We have recently made an investment in a £3.1m seed funding round in to AudioTelligence for the University of Cambridge Enterprise Fund V.

AudioTelligence is delivering real-time audio processing technology for the enhancement of Automatic Speech Recognition (ASR) systems.

Speech control is being used increasingly in consumer electronics, with smart speakers being the world’s fastest-growing consumer […]

NuNano – University of Bristol Enterprise Fund II investment

By |September 18th, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in NuNano.

NuNano specialise in the design of cantilever-based sensor devices and probes for atomic force microscopy. Microcantilevers are the simplest form of microelectromechanical systems (MEMS), which have come to prominence in the last decade or so. The basic […]

Exonate – University of Bristol Enterprise Fund II investment

By |September 17th, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Exonate.

Exonate are developing a novel approach to modulating new vessel growth.  By controlling the balance of two contrasting forms of a protein called Vascular Endothelial Growth Factor (VEGF), they have demonstrated that they could not only treat models […]

Lettus Grow – University of Bristol Enterprise Fund II investment

By |September 1st, 2018|

We are delighted to announce that the University of Bristol Enterprise Fund II, managed by Parkwalk, has invested in Lettus Grow.

Lettus Grow is a Bristol-based company supported by the award winning SETSquared incubator and the Oracle Global Cloud Accelerator. The company has developed a novel irrigation system to increase productivity in food production, with early […]

28 August 2018

Arago Bioscience – University of Oxford Innovation Fund IV investment

By |August 28th, 2018|

We are delighted to announce that the University of Oxford Innovation Fund IV has invested in Arago Biosciences alongside Oxford Sciences Innovation. Arago has designed the world’s most sensitive light microscope.

Arago Biosciences, a spin-out company from the University of Oxford’s Department of Chemistry, has designed a new way of detecting and quantifying molecules. The […]